September 18, 2014 | According to a “Bloomberg” report, Israel Chemicals may use its upcoming IPO on the New York Stock Exchange in order to delist from the Tel Aviv Stock Exchange. The move may be taken by the company in order to pressure the Israeli government into easing the new regulatory tax and royalty regime that is currently being considered by the Sheshinski II committee. Israel Chemicals has the second largest market cap on the TASE, and has already threatened to reduce activities and investments if the government does not meet its demands. Israel Chemicals commented in response that it does not plan to delist from the TASE.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
![](https://nocamels.com/wp-content/uploads/2018/02/INSIGHTEC-350x180.jpg)
Israeli Ultrasound Creator Collaborating On Neuroscience R&D In US
September 05, 2024
![The Weizmann Institute of Science. Photo via the Weizmann Institute of Science](https://nocamels.com/wp-content/uploads/2018/07/weizmann-350x252.jpg)
Weizmann In World’s Top 10 For Biomedical And Overall Research
September 05, 2024
![](https://nocamels.com/wp-content/uploads/2024/09/Depositphotos_75148477_L-350x228.jpg)
Israeli NGO Begins New Mental Health Training In Ukraine
September 04, 2024
![](https://nocamels.com/wp-content/uploads/2024/09/17123254699_79ff768811_ks-350x213.jpg)
Nonprofit Launches Loans For Stricken Northern Israel Businesses
September 04, 2024
Facebook comments